NCAPG Is a Promising Therapeutic Target Across Different Tumor Types

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types

BackgroundWith the advent of CRISPR-Cas9 genome editing tool in gene therapy, identification of aberrantly expressed genes is of great value across various cancer types. Since a large number of patients may benefit from molecular targeted gene therapy. The purpose of this study was to identify aberr...

Full description

Bibliographic Details
Main Authors: Cuicui Xiao, Jiao Gong, Yusheng Jie, Jing Cao, Zhongcheng Chen, Rong Li, Yutian Chong, Bo Hu, Qi Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pharmacology
Subjects:
RNA sequencing
pan-cancer analysis
The Cancer Genome Atlas; Non-SMC condensin I complex subunit G
hepatocellular carcinoma weighted gene co-expression network analysis
bioinformatic analysis
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00387/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00387/full

Similar Items